Barclays Upgrades Novartis (NVS) to Equalweight

June 23, 2017 5:53 AM EDT Send to a Friend

Barclays upgraded Novartis (NYSE: NVS) from Underweight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Barclays Upgrades Novartis (NVS) to Equalweight

Member Login

Free News Feed